IJ Anosike, M.D., M.P.H., assistant professor of pediatrics at the Montefiore Medical Center in the Bronx, explains how COVID ...

Chronic and acute graft-versus-host disease are managed differently, affect different organs, and impact patients in ...

The CDC’s Timothy M. Uyeki, M.D, however, cautioned that if the virus changes, and especially if it begins to infect pigs, ...

Only 15% of those who start a glucagon-like peptide 1 (GLP-1) for weight loss are still taking it two years according to ...

The FDA has already made more than a dozen cancer drug approval decisions this year and more expected in the next several ...

There have been developments in LASIK surgery improving outcomes for patients. George O. Waring, IV, M.D., founder and medical director of the Waring Vision Institute, discussed how new technology ...

One of two new studies found most patients doing well six years after treatment. Another study found blood cancers in 17% of ...

Kristen Whelchel, Pharm.D., CSP, Research and Patient Care Improvement Pharmacist with Vanderbilt Specialty Pharmacy's Department of Health Outcomes and Research, explains how technology identifies at ...

Statins have had an evolving role in the management of cardiovascular risk in people living with HIV, explained Michelle Cespedes, M.D., M.S., professor of medicine, Icahn School of Medicine at Mount ...

Research might produce treatments of involving transplants with a few, selected types of bacteria tailored to an individual's ...

After expansion of Medicaid, there was a significant decrease in the low-income population with no healthcare coverage.